Oxybutynin transdermal device having decreased delamination

Details Oxybutynin transdermal device having decreased delamination Oxybutynin transdermal device having decreased delamination

1995-06-07

1997-03-25

Phelan, D. Gabrielle

Drug, bio-affecting and body treating compositions

Preparations characterized by special physical form

Web, sheet or filament bases; compositions of bandages; or...

424449, A61F 1300

Patent

active

056142110

ABSTRACT:
A device for the transdermal administration of oxybutynin comprising a microporous tie layer located between the oxybutynin reservoir and the contact adhesive. The tie layer eliminates blooming and delamination and has no appreciable adverse effect on either the oxybutynin flux or release rate from the device.

REFERENCES:
patent: 4262003 (1981-04-01), Urquhart et al.
patent: 4379454 (1983-04-01), Campbell et al.
patent: 4542013 (1985-09-01), Keith
patent: 4687476 (1987-08-01), Pailin
patent: 4784857 (1988-11-01), Berry et al.
patent: 4817594 (1989-04-01), Juhasz
patent: 4904475 (1990-02-01), Gale et al.
patent: 4915950 (1990-04-01), Miranda et al.
patent: 4938964 (1990-07-01), Sakai et al.
patent: 5217718 (1993-06-01), Colley et al.
patent: 5234690 (1993-08-01), Chiang et al.
patent: 5273756 (1993-12-01), Fallon et al.
patent: 5298258 (1994-03-01), Akemi et al.
patent: 5314694 (1994-05-01), Gale
patent: 5411740 (1995-05-01), Lee et al.

Affiliated with

Also associated with

Rating

Oxybutynin transdermal device having decreased delamination does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Oxybutynin transdermal device having decreased delamination, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Oxybutynin transdermal device having decreased delamination will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2201215